| P50 | author | Elaine Tuomanen | Q24852303 |
| P2093 | author name string | Jason W Rosch | |
| | Beth Mann | |
| | Amy Iverson | |
| | Hannah M Rowe | |
| | Aaron Poole | |
| P2860 | cites work | Pneumococcal conjugate vaccines for preventing otitis media | Q24197520 |
| | Nonencapsulated Streptococcus pneumoniae: Emergence and Pathogenesis | Q26752517 |
| | Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates | Q33374646 |
| | The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia | Q34002787 |
| | Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. | Q34009174 |
| | The microbiologic and immunologic basis for recurrent otitis media in children | Q34320861 |
| | Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes | Q35086886 |
| | Mechanisms of genome evolution of Streptococcus | Q35476337 |
| | Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age. | Q35649092 |
| | Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. | Q35689099 |
| | Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis | Q35826641 |
| | Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children | Q35887453 |
| | Pneumolysin in the immunopathogenesis and treatment of pneumococcal disease | Q35917193 |
| | Identification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice. | Q36005317 |
| | Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection | Q36087567 |
| | Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines | Q36156085 |
| | Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae | Q36394058 |
| | Dynamic capsule restructuring by the main pneumococcal autolysin LytA in response to the epithelium | Q36637229 |
| | Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings | Q36759984 |
| | Association of nasopharyngeal bacterial colonization during upper respiratory tract infection and the development of acute otitis media. | Q37253928 |
| | Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland | Q37445704 |
| | Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen | Q37619137 |
| | Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein | Q37635127 |
| | Otitis-Prone Children Produce Functional Antibodies to Pneumolysin and Pneumococcal Polysaccharides. | Q37683735 |
| | New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine | Q38363735 |
| | Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study. | Q38378380 |
| | Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitations | Q39294069 |
| | Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children | Q39656521 |
| | Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants | Q40046987 |
| | Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. | Q40101888 |
| | Nasopharyngeal polymicrobial colonization during health, viral upper respiratory infection and upper respiratory bacterial infection | Q40241411 |
| | Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae | Q41080026 |
| | Live attenuated influenza virus increases pneumococcal translocation and persistence within the middle ear. | Q41600044 |
| | A study of the genetic material determining an enzyme activity in Pneumococcus | Q44711463 |
| | The mechanism of pneumolysin-induced cochlear hair cell death in the rat. | Q46624496 |
| | The variome of pneumococcal virulence factors and regulators. | Q47140241 |
| | A review of Haemophilus influenzae disease in Europe from 2000-2014: challenges, successes and the contribution of hexavalent combination vaccines | Q47877094 |
| | Sequence stability of the gene encoding outer membrane protein P2 of nontypeable Haemophilus influenzae in the human respiratory tract. | Q51726220 |
| | Etiology of Acute Otitis Media and Characterization of Pneumococcal Isolates After Introduction of 13-Valent Pneumococcal Conjugate Vaccine in Japanese Children. | Q54096671 |
| | Impact of PCV7 on invasive pneumococcal disease among children younger than 5 years: a population-based study | Q56894914 |
| | Nasopharyngeal carriage with Streptococcus pneumoniae augments the immunizing effect of pneumolysin toxoid B | Q58043338 |
| | Effect of Vaccination on Pneumococci Isolated from the Nasopharynx of Healthy Children and the Middle Ear of Children with Otitis Media in Iceland | Q59807597 |
| | Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain | Q60301335 |
| | Biofilm production by Haemophilus influenzae and Streptococcus pneumoniae isolated from the nasopharynx of children with acute otitis media | Q60910648 |
| | PCV7- and PCV10-Vaccinated Otitis-Prone Children in New Zealand Have Similar Pneumococcal and Densities in Their Nasopharynx and Middle Ear | Q64229637 |
| | Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent community-acquired pneumonia: identification of nontypeable Haemophilus influenzae as a major pathogen | Q84235781 |
| | Characterization of the interactions of the pneumolysoid, Δ6 PLY, with human neutrophils in vitro | Q85035968 |
| | Reduction in All-Cause Acute Otitis Media in Children <3 Years of Age in Primary Care Following Vaccination With 10-Valent Pneumococcal Haemophilus influenzae Protein-D Conjugate Vaccine: A Whole-Population Study | Q88265486 |
| | National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5 years in the United States | Q91251831 |
| | Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children | Q91329233 |
| | Does pneumococcal conjugate vaccination affect onset and risk of first acute otitis media and recurrences? A primary care-based cohort study | Q91435796 |
| P433 | issue | 10 | |
| P921 | main subject | Streptococcus pneumoniae | Q221179 |
| | acute otitis media | Q864028 |
| | Haemophilus influenzae | Q1141979 |
| P577 | publication date | 2019-09-19 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | A Cross-Reactive Protein Vaccine Combined with PCV-13 Prevents Streptococcus pneumoniae- and Haemophilus influenzae-Mediated Acute Otitis Media | |
| P478 | volume | 87 | |